Charles Schwab Investment Management Inc Scopus Bio Pharma Inc. Transaction History

Charles Schwab Investment Management Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$5.17 - $10.25 $61,057 - $121,052	-11,810 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.94 - $14.87 $93,771 - $175,614	11,810 New	11,810 $100,000

100

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.